High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
Crossref DOI link: https://doi.org/10.1038/s41598-018-20217-3
Published Online: 2018-02-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guerrero-MartÃnez, Jose A.
Reyes, Jose C.
Text and Data Mining valid from 2018-02-01
Version of Record valid from 2018-02-01
Article History
Received: 21 July 2017
Accepted: 16 January 2018
First Online: 1 February 2018
Competing Interests
: The authors declare that they have no competing interests.